SteriLance Medical sponsored the 2024 World Diabetes Day event in Beijing, showcasing its advanced insulin pen needles and other innovative solutions for diabetes management.
SteriLance Medical showcased its innovative products and commitment to healthcare excellence at MEDICA 2024, highlighting its advanced blood collection devices, insulin pen needles, and surgical solutions.
SteriLance Medical was recognized as the Best Medical Enterprise Partner at the 9th International Clinical Engineering Day Global Academic Conference and the 15th 'China Excellent Clinical Engineer' Competition Finals.
SteriLance Medical participated in CMEF 2024 in Shenzhen, showcasing innovations in medical devices and strengthening partnerships with global industry leaders.
A study in the International Journal of Biomedical Engineering and Technology emphasizes the benefits of Sandstone's insulin pen needle design, including improved resistance to tilting and reduced deformation.
SteriLance Medical received the 2022 Suzhou Quality Award, recognizing its leadership in product quality, innovation, and customer satisfaction in the capillary blood collection industry.
SteriLance Medical was recognized in Suzhou’s Intellectual Property Peak Action Project for its leadership in high-value patents and innovation. With 154 patents and 124 trademarks, SteriLance advances its IP strategy to enhance competitiveness.
The "Disposable Safety Heel Incision Lancet," developed and produced by SteriLance Medical, has been honored with the China Patent Excellence Award at the 22nd China Patent Awards, hosted by the China National Intellectual Property Administration.